IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell therapy targets autoimmune diseases in new trial
Disease control Not yet recruitingThis study tests a new treatment called CD19 UCAR-T cells for people with autoimmune diseases like lupus, vasculitis, and Sjögren's syndrome. The goal is to see if it is safe and can control the disease. About 24 adults aged 18 to 65 will take part. The treatment uses modified im…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New combo therapy aims to boost platelet counts in ITP patients
Disease control Not yet recruitingThis study tests different doses of zanubrutinib, taken with high-dose dexamethasone, in 60 adults newly diagnosed with immune thrombocytopenia (ITP). The goal is to find the safest and most effective dose to raise platelet counts and prevent bleeding. Participants will be follow…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Engineered immune cells take aim at stubborn autoimmune disease
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called universal STAR-T cells in people with autoimmune diseases that cause dangerously low platelet counts. About 6 adults aged 18-65 will receive a single infusion of these engineered cells to see if they are safe and can help con…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Jian Zhu • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Gene clues may unlock mystery of two blood disorders
Knowledge-focused Not yet recruitingThis study looks at two genes, IL-1β and IL-33, in 300 adults with either primary immune thrombocytopenia (ITP) or lupus-related low platelets. The goal is to see if these genes can help doctors tell the two conditions apart more easily. Participants will give a blood sample, and…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC
-
Real-World data sought on eltrombopag for low platelet disorder
Knowledge-focused Not yet recruitingThis study looks at how eltrombopag is used in routine care for adults with primary immune thrombocytopenia (ITP) who have already tried steroids. Researchers will collect information from doctors in the US, UK, and Germany about treatment patterns and platelet responses. No new …
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC